Nomination Summary for Trimethoprim/Sulfamethoxizole (N92202)
Nominated Substances: Trimethoprim/sulfamethoxazole (commercial)
Nomination Date: 01/29/1992
Nominator: NCI
Rationale: Significant human exposure as extensively used drug for treatment of urinary tract infections and pneumonia caused by p. Carinii (PCP) and its potential use in AIDS patients with PCP.